This update shows that the second trimester is associated with the most aggressive histopathological characteristics, and the third trimester with the most advanced disease stage, which is in line with the Swedish study of Gkekos et al. [20] Our findings for PABC overall also align with previous literature, highlighting enrichment of triple-negative and HER2-positive subtypes, a higher tumor grade, and more advanced stage at diagnosis. The gene discussed is ERBB2; the disease is neoplasm.